Park Square places Steven Basta as Chief Executive Officer at SaNOtize.
SaNOtize Research and Development Corp. (“SaNOtize”), a Canadian anti-infective-focused therapeutics company, today announced that the company has appointed Steven Basta, an experienced biopharma and medical device commercial leader, as its new Chief Executive Officer (CEO). Co-Founder Gilly Regev, PhD, will transition from her role as CEO to Chief Strategy and Innovation Officer at SaNOtize and will remain a member of its Board of Directors.
![featured image](https://images.passle.net/fit-in/860x860/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/58a5d143b00e8110e83aa6e5/2023-10-24-02-20-05-197-653729d55451ba025a954c3b.jpg)